Learn About Ampullary Cancer

What is the definition of Ampullary Cancer?
Ampullary cancer is a rare cancer of the ampulla of Vater. The ampulla of Vater is a small opening that is part of the digestive system located by the small intestine where the bile duct and pancreatic duct join. Ampullary cancer can also form near or spread to the liver and pancreas.
Save information for later
Sign Up
What are the symptoms of Ampullary Cancer?
Symptoms of ampullary cancer include jaundice (yellowing of the skin and eyes); itchy skin; anemia; fever; loss of appetite; nausea; vomiting; abdominal pain; gastrointestinal bleeding; rectal bleeding; back pain; pancreatitis; pale, greasy stools; diarrhea; and weight loss.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Ampullary Cancer?
Treatments for ampullary cancer include minimally-invasive surgery (endoscopic resection); laser ablation; open surgery (Whipple procedure, or pancreaticoduodenectomy, in which the head of the pancreas, duodenum, gallbladder, part of the common bile duct, part of the stomach, and nearby lymph nodes are removed); stent placement to drain bile and pancreatic enzymes; chemotherapy; and combined chemotherapy and radiation therapy.
Who are the top Ampullary Cancer Local Doctors?
Elite
Elite
 
 
 
 
Learn about our expert tiers
Learn more
Elite
What are the latest Ampullary Cancer Clinical Trials?
A Pragmatic, Single-Arm Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy
Summary: The study is testing an intervention of an investigator-developed chemotherapy dose adjustment algorithm. The primary objective of this study is to evaluate the effectiveness of the chemotherapy dose adjustment algorithm for reducing unplanned delays in patients receiving FOLFOX (5-fluorouracil, leucovorin, and oxaliplatin)-type chemotherapy, while maintaining acceptable chemotherapy dose-intensit...
Match to trials
Find the right clinical trials for you in under a minute
Get started
Quebec Pancreas Cancer Study
Summary: The Quebec Pancreas Cancer Study is a prospective clinic-based study consisting of clinical, family history and epidemiologic data, with accompanying biospecimens, from patients diagnosed with either pancreas cancer, a related cancer or a related pre-cancerous condition, and their families.
What are the Latest Advances for Ampullary Cancer?
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.
Summary: Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.
Second-line Chemotherapy Prolongs Survival in Real World Patients With Advanced Biliary Tract and Gallbladder Cancers: A Multicenter Retrospective Population-based Cohort Study.
Summary: Second-line Chemotherapy Prolongs Survival in Real World Patients With Advanced Biliary Tract and Gallbladder Cancers: A Multicenter Retrospective Population-based Cohort Study.
Tired of the same old research?
Check Latest Advances
A Case of Liver Metastases of Ampullary Carcinoma with Clinical Complete Response Treated with Gemcitabine plus Cisplatin.
Summary: A Case of Liver Metastases of Ampullary Carcinoma with Clinical Complete Response Treated with Gemcitabine plus Cisplatin.